ヒトミルクオリゴ糖市場：製品、タイプ、用途別-2025年～2030年世界予測

ヒトミルクオリゴ糖市場は、2023年に2億9,790万米ドルと評価され、2024年には3億2,344万米ドルに達すると予想され、CAGR 9.72％で成長し、2030年には5億7,055万米ドルに達すると予測されています。

ヒトミルクオリゴ糖（HMO）は、ヒト母乳中に見出される複合糖質の特殊なグループを表し、乳児の栄養と発育に重要な役割を果たします。HMOは、有益な腸内細菌の増殖の支援、免疫機能の強化、粘膜表面での病原体との結合の抑制など、様々な健康上の利点をもたらす200以上の構造から構成されています。機能性食品と乳児栄養の市場が拡大するにつれて、HMOは乳児用調製粉乳、サプリメントおよび機能性食品におけるその潜在的用途がますます認識され、栄養と薬用の両方の目的に役立っています。最終用途の範囲は乳児用栄養、成人用サプリメント、治療薬にまたがり、乳児用調製粉乳分野は母乳育児の代替品としての需要の高まりにより最も大きな推進力となっています。市場成長は主に、HMOの健康上の利点に対する意識の高まり、製造方法における技術的進歩、代替栄養への親の関心の高まりに影響されます。しかしながら、HMOの効果的な大量生産と安定性には、高い生産コスト、規制上のハードル、技術的課題を含む大きな課題があります。微生物発酵のような効率的な合成技術は、コスト削減と拡張性の向上を約束する機会です。重要な勧告は、費用対効果の高い生産工程を革新し、薬事承認を拡大するための共同研究とパートナーシップに焦点を当てることです。個別化栄養、特に成人向けサプリメントや腸の健康への応用の可能性は大きく、市場拡大の新たな道を提供します。しかし、消費者の認識や受容、地域間の複雑な規制状況への対応などの限界は、継続的な課題となっています。企業にとっての技術革新の分野には、特定の健康状態に対するオーダーメイドのHMO配合や、多様な食品に対する強化方法が含まれます。市場は急速な技術革新と特許活動によって特徴付けられ、競争力を維持するために研究と戦略的パートナーシップにおける積極的な姿勢が必要とされ、品質と効能の一貫性は極めて重要な競争決定要因です。

市場力学：急速に進化するヒトミルクオリゴ糖市場の主要市場インサイトを公開

ヒトミルクオリゴ糖市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 栄養価による乳児用調製粉乳および機能性食品へのHMO適用増加
  • 世界中で子どもの栄養不良と死亡率に関する懸念に関する意識の高まり
  • 成人におけるHMOsサプリメントの需要の増加
• 市場抑制要因
  • 研究開発と大量生産に伴う高コスト
• 市場機会
  • HMOs製品ラインの進歩
  • 中国とインドからの栄養補助食品需要の増加
• 市場の課題
  • 国及び地域特有の規制枠組み

ポーターの5つの力：ヒトミルクオリゴ糖市場をナビゲートする戦略的ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ヒトミルクオリゴ糖市場における外部からの影響の把握

外部マクロ環境要因は、ヒトミルクオリゴ糖市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヒトミルクオリゴ糖市場における競合情勢の把握

ヒトミルクオリゴ糖市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヒトミルクオリゴ糖市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヒトミルクオリゴ糖市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 栄養価を考慮し、乳児用調製粉乳や機能性食品へのHMOの適用を拡大
    • 世界中で子供の栄養失調と死亡に関する懸念に対する意識が高まる
    • 成人におけるHMOサプリメントの需要増加
  • 抑制要因
    • 研究開発と大量生産に伴う高コスト
  • 機会
    • HMOの製品ラインの進化
    • 中国とインドからの栄養補助食品の需要増加
  • 課題
    • 国や地域特有の規制枠組み
• 市場セグメンテーション分析
  • 製品：母乳に豊富に含まれ、健康上の利点が実証されているため、2'-フコシルラクトース（2'FL）の好感度が高まっています。
  • 用途：乳児の母乳の複雑な健康維持特性を再現するためのHMOの応用が拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 ヒトミルクオリゴ糖市場：製品別

• 2'-フコシルラクトース（2'FL）
• 3'-フコシルラクトース（3'FL）
• 3'-シアリルラクトース（3'SL）
• 6'-シアリルラクトース（6'SL）
• ラクト-n-ネオテトラオース（LNnT）
• ラクト-n-テトラオース（LNT）

第7章 ヒトミルクオリゴ糖市場：タイプ別

• 酸性
• 中性

第8章 ヒトミルクオリゴ糖市場：用途別

• 機能性食品とサプリメント
• 乳児用調合乳
• 研究室調査

第9章 南北アメリカのヒトミルクオリゴ糖市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のヒトミルクオリゴ糖市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのヒトミルクオリゴ糖市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • ネスレはHMOを使用した初の製品を中国で発売し、栄養科学における世界のリーダーシップを強化しました。
  • フィルメニッヒ、DSMとの対等合併を完了
  • ノボザイムズ、123億米ドルでクリスチャン・ハンセンを買収することに合意

企業一覧

• Abbott Laboratories
• Advanced Protein Technologies Corp.
• Agilent Technologies, Inc.
• BASF SE
• Biosynth AG
• Chr. Hansen Holding A/S
• Conagen, Inc.
• Dextra Laboratories Ltd
• DuPont de Nemours, Inc.
• Elicityl SA
• Glycosyn LLC
• Gnubiotics Sciences SA
• Inbiose NV
• Kirin Holdings Company, Limited
• Koninklijke DSM N.V.
• Laita Nutrition
• Lonza Group AG
• Nestle S.A.
• Roquette Freres
• Royal FrieslandCampina N.V.
• Tate & Lyle PLC
• TurtleTree
• ZuChem, Inc.

LIST OF FIGURES

• FIGURE 1. HUMAN MILK OLIGOSACCHARIDES MARKET RESEARCH PROCESS
• FIGURE 2. HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HUMAN MILK OLIGOSACCHARIDES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HUMAN MILK OLIGOSACCHARIDES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HUMAN MILK OLIGOSACCHARIDES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HUMAN MILK OLIGOSACCHARIDES MARKET DYNAMICS
• TABLE 7. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 2'-FUCOSYLLACTOSE(2'FL), BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 3'-FUCOSYLLACTOSE (3'FL), BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 3'-SIALYLLACTOSE (3'SL), BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY 6'-SIALYLLACTOSE (6'SL), BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY LACTO-N-NEOTETRAOSE (LNNT), BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY LACTO-N-TETRAOSE (LNT), BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY ACIDIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY NEUTRAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY FUNCTIONAL FOOD & SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY INFANT FORMULAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY LABORATORY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. CANADA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. CHINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CHINA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. ITALY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ITALY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. POLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. POLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. QATAR HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. QATAR HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM HUMAN MILK OLIGOSACCHARIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. HUMAN MILK OLIGOSACCHARIDES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. HUMAN MILK OLIGOSACCHARIDES MARKET, FPNV POSITIONING MATRIX, 2023

The Human Milk Oligosaccharides Market was valued at USD 297.90 million in 2023, expected to reach USD 323.44 million in 2024, and is projected to grow at a CAGR of 9.72%, to USD 570.55 million by 2030.

Human Milk Oligosaccharides (HMOs) represent a specialized group of complex carbohydrates found in human breast milk, playing a crucial role in infant nutrition and development. They are composed of over 200 structures that confer various health benefits, including supporting the growth of beneficial gut bacteria, enhancing immune function, and inhibiting pathogen binding at mucosal surfaces. As the market for functional foods and infant nutrition expands, HMOs are increasingly recognized for their potential applications in infant formula, supplements, and functional foods, serving both nutritional and medicinal purposes. The end-use scope spans across infant nutrition, adult supplements, and therapeutics, with the infant formula segment being the most substantial driver due to rising demand for breastfeeding alternatives. Market growth is primarily influenced by the increasing awareness of HMOs' health benefits, technological advancements in production methods, and rising parental interest in feeding alternatives. However, there are significant challenges, including high production costs, regulatory hurdles, and technical challenges in effective mass production and stability of HMOs. Opportunities lie in efficient synthesis technologies, such as microbial fermentation, which promise cost reduction and increased scalability. A key recommendation is to focus on collaborative research and partnerships to innovate cost-effective production processes and expand regulatory approvals. The potential for personalized nutrition, especially in adult supplements and gut health applications, is significant, providing new avenues for market expansion. However, limitations such as consumer awareness and acceptance, and navigating complex regulatory landscapes across regions, pose ongoing challenges. For businesses, areas of innovation include tailor-made HMO blends for specific health conditions and fortification methods for diverse food products. The market is characterized by rapid innovation and patent activities, necessitating a proactive stance in research and strategic partnerships to remain competitive, with consistency in quality and efficacy being a vital competitive determinant.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Milk Oligosaccharides Market

The Human Milk Oligosaccharides Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase HMO Application in Infant Formula and Functional Food owing to the Nutritional Value
  • Rising Awareness Regarding the Concerns Related to Child Malnourishment and Mortality all Over the Globe
  • Increasing Demand for HMOs Supplements in Adults
• Market Restraints
  • High Cost associated with the R&D and Large Production
• Market Opportunities
  • Advancement in the Product Line of HMOs
  • Rising Demand for Nutritional Supplements from China and India
• Market Challenges
  • Regulatory Framework Specific to Countries and Regions

Porter's Five Forces: A Strategic Tool for Navigating the Human Milk Oligosaccharides Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Milk Oligosaccharides Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Milk Oligosaccharides Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Milk Oligosaccharides Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Milk Oligosaccharides Market

A detailed market share analysis in the Human Milk Oligosaccharides Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Milk Oligosaccharides Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Milk Oligosaccharides Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Human Milk Oligosaccharides Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Protein Technologies Corp., Agilent Technologies, Inc., BASF SE, Biosynth AG, Chr. Hansen Holding A/S, Conagen, Inc., Dextra Laboratories Ltd, DuPont de Nemours, Inc., Elicityl SA, Glycosyn LLC, Gnubiotics Sciences SA, Inbiose NV, Kirin Holdings Company, Limited, Koninklijke DSM N.V., Laita Nutrition, Lonza Group AG, Nestle S.A., Roquette Freres, Royal FrieslandCampina N.V., Tate & Lyle PLC, TurtleTree, and ZuChem, Inc..

Market Segmentation & Coverage

This research report categorizes the Human Milk Oligosaccharides Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across 2'-Fucosyllactose(2'FL), 3'-Fucosyllactose (3'FL), 3'-Sialyllactose (3'SL), 6'-Sialyllactose (6'SL), Lacto-n-neotetraose (LNnT), and Lacto-n-tetraose (LNT).
• Based on Type, market is studied across Acidic and Neutral.
• Based on Application, market is studied across Functional Food & Supplements, Infant Formulas, and Laboratory Research.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase HMO Application in Infant Formula and Functional Food owing to the Nutritional Value
    • 5.1.1.2. Rising Awareness Regarding the Concerns Related to Child Malnourishment and Mortality all Over the Globe
    • 5.1.1.3. Increasing Demand for HMOs Supplements in Adults
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost associated with the R&D and Large Production
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement in the Product Line of HMOs
    • 5.1.3.2. Rising Demand for Nutritional Supplements from China and India
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory Framework Specific to Countries and Regions
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing preference for 2'-Fucosyllactose(2'FL) due to its abundance in human milk and proven health benefits
  • 5.2.2. Application: Growing application of HMOs for replicating the complex health-sustaining properties of breast milk for infants
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Human Milk Oligosaccharides Market, by Product

• 6.1. Introduction
• 6.2. 2'-Fucosyllactose(2'FL)
• 6.3. 3'-Fucosyllactose (3'FL)
• 6.4. 3'-Sialyllactose (3'SL)
• 6.5. 6'-Sialyllactose (6'SL)
• 6.6. Lacto-n-neotetraose (LNnT)
• 6.7. Lacto-n-tetraose (LNT)

7. Human Milk Oligosaccharides Market, by Type

• 7.1. Introduction
• 7.2. Acidic
• 7.3. Neutral

8. Human Milk Oligosaccharides Market, by Application

• 8.1. Introduction
• 8.2. Functional Food & Supplements
• 8.3. Infant Formulas
• 8.4. Laboratory Research

9. Americas Human Milk Oligosaccharides Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Human Milk Oligosaccharides Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Human Milk Oligosaccharides Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Nestle launches its first product with HMOs in China, reinforcing its global leadership in nutrition science
  • 12.3.2. Firmenich Completes Merger Of Equals With Dsm
  • 12.3.3. Novozymes Agrees to Buy Chr. Hansen in USD 12.3 Billion Deal

Companies Mentioned

• 1. Abbott Laboratories
• 2. Advanced Protein Technologies Corp.
• 3. Agilent Technologies, Inc.
• 4. BASF SE
• 5. Biosynth AG
• 6. Chr. Hansen Holding A/S
• 7. Conagen, Inc.
• 8. Dextra Laboratories Ltd
• 9. DuPont de Nemours, Inc.
• 10. Elicityl SA
• 11. Glycosyn LLC
• 12. Gnubiotics Sciences SA
• 13. Inbiose NV
• 14. Kirin Holdings Company, Limited
• 15. Koninklijke DSM N.V.
• 16. Laita Nutrition
• 17. Lonza Group AG
• 18. Nestle S.A.
• 19. Roquette Freres
• 20. Royal FrieslandCampina N.V.
• 21. Tate & Lyle PLC
• 22. TurtleTree
• 23. ZuChem, Inc.